We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Modafinil is approved to treat excessive somnolence but it is also off-spec used as a treatment for ADHD and as a cognitive enhancer. Research on the effects of modafinil on cognitive function have yielded mixed results. Modafinil interact with dopamine, noradrenaline, serotonin, glutamate, orexin, histamine and GABA levels. The regulation of these neurotransmitters is widely known to be implicated in most of the neuropsychiatric disorders.
Methodology
A review was conducted aiming to clarify the biological mechanisms of action of modafinil; its effects on attention, learning, executive functions and creative thinking; as well as possible neuropsychiatric disorders associated to its intake. The literature search was conducted in PubMed data reviewing articles dating between 2015 and 2016.
Results
(1) Empirical evidence for cognitive enhancing effects of one of the most frequently used substances, modafinil, is sparse. Studies suggest that with more protracted and complex testing, more benefits are associated to modafinil use.
(2) Modafinil may be implicated in alterations of reward-related behaviour. Compared to placebo, modafinil leads to an enhanced tendency to make previously rewarded choices compared to the avoidance of previously punished choices. This pattern of altered choice behaviour is probably induced by an increase of the dopamine level and a potential contribution of elevated noradrenaline.
Conclusions
Some people share information about this drug in social network. Off-label use of this drug may be implicated in alterations of reward-related behaviour and patients with previous psychiatric disorders should be aware of its possible adverse effects.
Disclosure of interest
The authors have not supplied their declaration of competing interest.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.